Utah Innovation Fund — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Rebel Medicinerebelmedicine.cominJun 2025 · $6M
Rebel Medicine develops preclinical investigational drugs and wound care products designed to provide pain relief without opioids.
BiotechHealthtechMedical DevicesSalt Lake City, US
Brett Davis(Executive Officer, Director)inCaleb Lade(Executive Officer, Director)
BoardJohn Poyhonen(Director)Kevin Passey(Director)Mai Nguyen(Director)
Co-investorsCentral Texas Angel Network
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.